Fatty Acids and Lypidic Derivatives

<p>Applications Azetidinone Ezetimibe (E975000) analog. A cholesterol absorption inhibitor.<br>References Hauser, H., et al.: Biochemistry, 37, 17843 (1998), Davis, et al.: Metabolism, 50, 1234 (2001), Berger., et al.: Therapeutics, 4, 163 (2002),<br></p>

<p>Applications 3-Methyl Hippuric Acid-d7 Is a substituted labelled hippurate analog as substrates and inhibitor of peptidylglycine α-hydroxylating monooxygenase (PHM).<br>References Kruse, L., et al.: J. Med. Chem., 33, 781 (1990), Jeng, A., et al.: J. Biol. Chem., 272, 14666 (1997), Schally, A., et al.: Horm. Metab. Res., 40, 315 (2008),<br></p>

<p>Applications An inhibitor of glucose synthesis.<br>References Martirosyan, A., et al.: Biochem. Pharmacol., 68, 1729 (2004),<br></p>

<p>Applications β-Muricholic Acid is an bile acid found in urine. β-Muricholic Acid has been used in studies of down regulation of transporter protein through ubiquitin dependent protein degradation.<br>References Miyata, M., et al.: Euro. J. Pharmacol., 714, 507 (2013);<br></p>

<p>Applications Triheptanoin is used in the in the alleviation of ventricular hypertrophy and improves myocardial glucose oxidation.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Nguyen, T. et al.: J. Cardiac Fail., 21, 906 (2015); Vockley, J. et al.: Mol. Gen. Metab., 116, 53 (2015);<br></p>

<p>Applications A metabolite of Atorvastatin, a selective, competitive HMG-CoA reductase inhibitor. Atorvastatin is the only drug in its class specfically indicated for lowering both elevated LDL-cholesterol and triglycerides in patients with hypercholesterolemia.<br>References Smith, S., et al.: Am. J. Cardiol., 80, 10H (1997), Jacobsen, W., et al.: Drug Metab. Dispos., 28, 1369 (2000), Istvan, E., et al.: Science, 292, 1160 (2001), Tabernero, L., et al.: J. Biol. Chem., 278, 19933 (2003), Bratton, L., et al.: Bioorg. Med. Chem., 15, 5576 (2007),<br></p>

<p>Impurity Orlistat USP Related Compound A<br>Applications (3S,4S)-3-Hexyl-4-[(2R)-2-hydroxytridecyl]-2-oxetanone (Orlistat USP Related Compound A) is an analog of Tetrahydrolipstatin, an inhibitor of the hydrolysis of endocannabinoid 2-arachidonoylglycerol (2-AG), also an intermediate in the preparation of Orlistat (O686500).<br>References Mechoulam, R., et al.: Biochem. Pharmacol., 50, 83 (1995), Bisogno, T., et al.: J. Cell Biol., 163, 463 (2003), Di Marzo, V., et al.: Nat. Rev. Drug Discovery, 7, 438 (2008), Ortar, G., et al.: J. Med. Chem., 51, 6970 (2008),<br></p>